0001209191-23-014628.txt : 20230302
0001209191-23-014628.hdr.sgml : 20230302
20230302161338
ACCESSION NUMBER: 0001209191-23-014628
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230222
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOTLER KEVIN
CENTRAL INDEX KEY: 0001601692
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 23699076
MAIL ADDRESS:
STREET 1: C/O BROADFIN CAPITAL, LLC
STREET 2: 300 PARK AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-02-22
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001601692
KOTLER KEVIN
4242 CAMPUS POINT COURT, SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
37879
D
Common Stock
540000
I
By Broadfin Holdings LLC
Stock Option (Right to Buy)
2.70
2033-02-22
Common Stock
227272
D
The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (02/22/2023).
The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023).
/s/ Lisa Peraza
Attorney-in-fact for Kevin Kotler
2023-03-02
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
I hereby constitute and appoint David Szekeres and Lisa Peraza as my true and
lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Heron Therapeutics, Inc. (the "Company"), Forms
3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended (the "Act"), and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and
(3) take any other action in connection with the foregoing which, in the opinion
of such attorney-in-fact, is intended to benefit, is in the best interest of, or
legally required by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve.
The undersigned hereby grants to each attorney-in-fact full power and authority
to do and perform any act requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming all
the acts such attorney-in-fact shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that each foregoing attorney-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming any of the
undersigned's responsibilities to comply with Section 16 of the Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date set forth below.
By: /s/ Kevin Kotler
Print Name: Kevin Kotler
Date: February 27, 2023